News

AddToAny

Google+ Facebook Twitter Twitter

Histopathology qualification funding

The IBMS has announced new funding support for Institute members undertaking IBMS/RCPath histopathology qualifications.

The IBMS has announced new funding support for Institute members undertaking IBMS/RCPath histopathology qualifications.

The funding will have a direct and positive impact on IBMS members who are currently enrolled, or about to enrol, via the pathology network route, to undertake our exams programme.

It also demonstrates a tremendous mark of confidence in the Institute’s professional examinations and underlines their value in the training of scientists to undertake advanced and consultant roles.

IBMS President, Allan Wilson, said: “This funding initiative is fantastic news for both scientists and patients moving forward.

“Histopathology laboratories have been under considerable pressure as demand for services increases.

“The funding will not only help to allay these pressures and give members the opportunity to undertake these new advanced roles, but also allow patients to reap the benefits of new developments in diagnostics, monitoring and therapy in cancer, assisting in future-proofing NHS cancer services.”  

For more information, visit bit.ly/2VEbzjv

Image Credit | iStock

Related Articles

Digital Pathology group

The IBMS discussion group for digital pathology is looking for new members to attend and facilitate at virtual meetings.

The British Journal of Biomedical Science: Issue 2 2021, Synopsis

Deputy Editor Guy Orchard provides a brief glimpse of the articles on offer in the second issue of 2021.

3D skin imaging

A portable device has been developed that produces high-resolution 3D images of human skin within 
10 minutes.

Medical eponmys pt4: Hodgkin disease

This is the fourth is a series of short biographies of persons whose names are directly used for diseases, conditions or syndromes familiar to those in clinical pathology labs. Their names are most often used because they made highly significant contributions to the discovery and understanding of the disease. 

Top